AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DPolaris Venture Partners Iv Lp • February 14th, 2019 • Pharmaceutical preparations
This Schedule 13D was executed pursuant to a Power of Attorney. Note that copies of the applicable Powers of Attorney are already on file with the appropriate agencies.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • May 13th, 2014 • Polaris Venture Partners Iv Lp • Biological products, (no disgnostic substances)
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate.
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DPolaris Venture Partners Iv Lp • April 21st, 2014 • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DPolaris Venture Partners Iv Lp • August 27th, 2015 • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DPolaris Venture Partners Iv Lp • February 14th, 2019 • Pharmaceutical preparations
STOCK PURCHASE AGREEMENTStock Purchase Agreement • April 7th, 2014 • Polaris Venture Partners Iv Lp • Biological products, (no disgnostic substances) • Delaware
STOCK PURCHASE AGREEMENT, dated as of April 2, 2014 (this “Agreement”), is made by and among Celgene Corporation, a Delaware corporation (“Buyer”), and Polaris Venture Partners Entrepreneurs Fund IV, L.P., a Delaware limited partnership, and Polaris Venture Partners IV, L.P., a Delaware limited partnership (collectively, the “Sellers”).
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DPolaris Venture Partners Iv Lp • May 26th, 2015 • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DPolaris Venture Partners Iv Lp • February 14th, 2014 • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DPolaris Venture Partners Iv Lp • February 17th, 2015 • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • April 7th, 2014 • Polaris Venture Partners Iv Lp • Biological products, (no disgnostic substances)
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate.
